Researchers analyzed the susceptibility profile of a colonizing CRE to forecast its susceptibility when recovered from a clinical specimen. Ultimately, the researchers observed an overall agreement of 88.7 percent for the combinations of 11 antibiotics with 53 pairs of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
That said, there were also considerable errors observed for aminoglycoside agents and colistin, meaning the predictability of the susceptibility profile for these clinical isolates is limited.
“We recommend caution when prior surveillance results are used to guide therapy,” the authors concluded.
More articles on CRE:
Could hospital waste hosting superbugs spread the bacteria to the public?
Study examines risk of CRE colonization becoming an infection: 3 findings
CDC report reveals CRE is on the rise: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.